"Physician-Based Point of Care Diagnostics: Products, Players and Outlook to 2017" Published
The market for Point-of-Care (POC) diagnostic products used in the physician's surgery was worth approximately US$1.7 billion in 2011 with sectors such as cholesterol testing and tumour markers making the best continued growth in the year. All sectors will see sustained growth over the medium term, with the total addressable market for products that can be potentially used in a physician's office forging ahead to be valued at over US$6.1 billion by 2017.
View full press release